You are here

Article metrics

Article menu

Download PDFPDF

Late-breaking abstracts
Combination immunotherapies
820 MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T cells

 

Online download statistics by month:

Online download statistics by month: November 2020 to October 2024

AbstractFullPdf
Nov 2020212024
Dec 202044013
Jan 202138012
Feb 202130019
Mar 202198022
Apr 202144010
May 202113011
Jun 20210015
Jul 2021009
Aug 2021006
Sep 20210012
Oct 2021114033
Nov 202150029
Dec 202140010
Jan 202266021
Feb 202222013
Mar 202232011
Apr 20227608
May 202274011
Jun 20224604
Jul 20226203
Aug 202290012
Sep 202246010
Oct 20226209
Nov 202282010
Dec 20224604
Jan 20232806
Feb 20233605
Mar 20232803
Apr 20233006
May 20232403
Jun 20232207
Jul 20232808
Aug 2023603
Sep 20232602
Oct 20233602
Nov 20232401
Dec 20233201
Jan 20241602
Feb 20242400
Mar 202422054
Apr 20248010
May 20242608
Jun 20242800
Jul 20241404
Aug 20241802
Sep 20241202
Oct 20242207
Total18970477